These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14999362)

  • 1. Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhaler.
    Rohatagi S; Chapel S; Kirkesseli S; Newman S; Zhang J; Paccaly D; Randall L; Wray H; Wellington S; Shah B; Jensen BK
    Am J Ther; 2004; 11(2):103-13. PubMed ID: 14999362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a dry powder inhaler, the Ultrahaler, containing triamcinolone acetonide using in vitro-in vivo relationships.
    Lim JG; Shah B; Rohatagi S; Bell A
    Am J Ther; 2006; 13(1):32-42. PubMed ID: 16428920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintigraphic assessment of drug delivery from the Ultrahaler dry powder inhaler.
    Pitcairn GR; Lim J; Hollingworth A; Newman SP
    J Aerosol Med; 1997; 10(4):295-306. PubMed ID: 10175961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on pharmacokinetics of an inhaled drug: a case study with a VLA-4 antagonist, HMR1031.
    Shah B; Jensen BK; Zhang J; Hunt T; Rohatagi S
    J Clin Pharmacol; 2003 Dec; 43(12):1341-9. PubMed ID: 14615470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer.
    Newman SP; Pitcairn GR; Adkin DA; Vidgren MT; Silvasti M
    J Aerosol Med; 2001; 14(2):217-25. PubMed ID: 11681653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
    Lähelmä S; Kirjavainen M; Kela M; Herttuainen J; Vahteristo M; Silvasti M; Ranki-Pesonen M
    Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
    Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
    J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
    Virgolini I; Kurtaran A; Leimer M; Smith-Jones P; Agis H; Angelberger P; Kletter K; Valent P; Linkesch W; Eichler HG
    J Nucl Med; 1997 Sep; 38(9):1475-81. PubMed ID: 9293812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic Assessment of Deposition of Radiolabeled Fluticasone Delivered from a Nebulizer and Metered Dose Inhaler in 10 Healthy Dogs.
    Chow KE; Tyrrell D; Yang M; Abraham LA; Anderson GA; Mansfield CS
    J Vet Intern Med; 2017 Nov; 31(6):1849-1857. PubMed ID: 28961322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
    Dahlström K; Thorsson L; Larsson P; Nikander K
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
    Poli G; Acerbi D
    Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
    Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
    Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.
    Newhouse MT; Hirst PH; Duddu SP; Walter YH; Tarara TE; Clark AR; Weers JG
    Chest; 2003 Jul; 124(1):360-6. PubMed ID: 12853545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
    Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system.
    Geller DE; Rosenfeld M; Waltz DA; Wilmott RW;
    Chest; 2003 Jan; 123(1):28-36. PubMed ID: 12527599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.